NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Monday, February 8, 2016

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.

It operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. In support of the Ethiopian Government’s National Strategic Action Plan for Non-Communicable Diseases, last week AstraZeneca launched the Healthy Heart Africa initiative to address the burden of hypertension for low and middle income patients across the Horn of Africa country.

This partnership was initiated in late-2015, when an agreement was signed between AstraZeneca and the Ethiopian government to provide a formal partnership framework.

Healthy Heart Africa’s expansion into Ethiopia comes on the heels of a successful series of Kenyan demonstration projects launched in October 2014.